Wednesday, 07 December 2022


Malaysian Genomics grows presence in Thailand

23 September 2022 | News

Group is collaborating with Thai partners to supply its products and services

Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, has announced a series of collaborations to grow its customer base in Thailand as well as exploring opportunities for research and development (R&D) of new products and services.

The Group signed a supply and collaboration agreement with Acquest Healthcare Stem Cell Research and Development to produce CAR T-cells for supply to Acquest's customers. Acquest is a well-established provider of various cell therapies to hospitals, specialist doctors, and patients in Thailand. It operates a state-of-the-art clinical laboratory and also the largest privately-owned specialty human cell culturing facility in the country.

The Group also signed a supply and collaboration agreement with Salus Holdings to supply biopharmaceutical and genomics products and services to Salus' customers. Salus is a specialist in wellness and health screening using science and technology for early disease detection and managing programmes for lifestyle intervention based in Bangkok, Thailand.

Finally, the Group signed a Letter of Intent with Marine Group and Salus on collaborative research in the use of genetic screening tests and formulated cosmetic products containing certain cell therapy ingredients on the regeneration of skin and hair of patients. Marine Group is an aesthetic and wellness specialist with a network of over 42 centres under the brands Slim Up, Skin Doctors, and Biocell.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account